252 related articles for article (PubMed ID: 15289371)
1. Endothelial dysfunction and mild renal insufficiency in essential hypertension.
Perticone F; Maio R; Tripepi G; Zoccali C
Circulation; 2004 Aug; 110(7):821-5. PubMed ID: 15289371
[TBL] [Abstract][Full Text] [Related]
2. Microalbuminuria, endothelial dysfunction and inflammation in primary hypertension.
Perticone F; Maio R; Tripepi G; Sciacqua A; Mallamaci F; Zoccali C
J Nephrol; 2007; 20 Suppl 12():S56-62. PubMed ID: 18050145
[TBL] [Abstract][Full Text] [Related]
3. Inflammation as a mediator of the link between mild to moderate renal insufficiency and endothelial dysfunction in essential hypertension.
Zoccali C; Maio R; Tripepi G; Mallamaci F; Perticone F
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S64-8. PubMed ID: 16565250
[TBL] [Abstract][Full Text] [Related]
4. Endothelial dysfunction and the kidney: emerging risk factors for renal insufficiency and cardiovascular outcomes in essential hypertension.
Zoccali C
J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S61-3. PubMed ID: 16565249
[TBL] [Abstract][Full Text] [Related]
5. Endothelial dysfunction contributes to renal function-associated cardiovascular mortality in a population with mild renal insufficiency: the Hoorn study.
Stam F; van Guldener C; Becker A; Dekker JM; Heine RJ; Bouter LM; Stehouwer CD
J Am Soc Nephrol; 2006 Feb; 17(2):537-45. PubMed ID: 16382015
[TBL] [Abstract][Full Text] [Related]
6. Endothelial dysfunction and C-reactive protein are risk factors for diabetes in essential hypertension.
Perticone F; Maio R; Sciacqua A; Andreozzi F; Iemma G; Perticone M; Zoccali C; Sesti G
Diabetes; 2008 Jan; 57(1):167-71. PubMed ID: 17928395
[TBL] [Abstract][Full Text] [Related]
7. Clinical profile and management of hypertensive patients with chronic ischemic heart disease and renal dysfunction attended by cardiologists in daily clinical practice.
Barrios V; Escobar C; Murga N; de Pablo C; Bertomeu V; Calderón A; Echarri R
J Hypertens; 2008 Nov; 26(11):2230-5. PubMed ID: 18854765
[TBL] [Abstract][Full Text] [Related]
8. Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study.
Redón J; Cea-Calvo L; Lozano JV; Fernández-Pérez C; Navarro J; Bonet A; González-Esteban J;
J Hypertens; 2006 Apr; 24(4):663-9. PubMed ID: 16531794
[TBL] [Abstract][Full Text] [Related]
9. Uric acid and endothelial dysfunction in essential hypertension.
Zoccali C; Maio R; Mallamaci F; Sesti G; Perticone F
J Am Soc Nephrol; 2006 May; 17(5):1466-71. PubMed ID: 16611716
[TBL] [Abstract][Full Text] [Related]
10. Hypertension, microalbuminuria and renal dysfunction: the Renal Dysfunction in Hypertension (REDHY) study.
Cerasola G; Mulè G; Cottone S; Nardi E; Cusimano P
J Nephrol; 2008; 21(3):368-73. PubMed ID: 18587725
[TBL] [Abstract][Full Text] [Related]
11. Mild to moderate renal impairment is associated with increased left ventricular mass.
Greaves K; Chen R; Ge L; Wei M; Tong B; Cai N; Senior R; Hemingway H
Int J Cardiol; 2008 Mar; 124(3):384-6. PubMed ID: 17399818
[TBL] [Abstract][Full Text] [Related]
12. [Serum creatinine and creatinine clearance to estimate renal function in essential hypertension].
Jabary NS; Martín D; Muñoz MF; Santos M; Herruzo J; Gordillo R; Bustamante J
Nefrologia; 2006; 26(1):64-73. PubMed ID: 16649427
[TBL] [Abstract][Full Text] [Related]
13. Lack of association between endothelial nitric oxide synthase gene polymorphisms, microalbuminuria and endothelial dysfunction in hypertensive men.
Dell'Omo G; Penno G; Pucci L; Fotino C; Lucchesi D; Del Prato S; Pedrinelli R
J Hypertens; 2007 Jul; 25(7):1389-95. PubMed ID: 17563560
[TBL] [Abstract][Full Text] [Related]
14. [Renal function and cardiovascular risk in patients with essential hypertension. The "FRESHA" study].
Herrero P; Marín R; Fernández Vega F; Gorostidi M; Riesgo A; Vázquez J; Díez Ojeda B;
Nefrologia; 2006; 26(3):330-8. PubMed ID: 16892821
[TBL] [Abstract][Full Text] [Related]
15. Vascular function and mild renal impairment in stable coronary artery disease.
van der Harst P; Smilde TD; Buikema H; Voors AA; Navis G; van Veldhuisen DJ; van Gilst WH
Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):379-84. PubMed ID: 16306429
[TBL] [Abstract][Full Text] [Related]
16. Endothelial dysfunction and subsequent decline in glomerular filtration rate in hypertensive patients.
Perticone F; Maio R; Perticone M; Sciacqua A; Shehaj E; Naccarato P; Sesti G
Circulation; 2010 Jul; 122(4):379-84. PubMed ID: 20625109
[TBL] [Abstract][Full Text] [Related]
17. Haematocrit, type 2 diabetes, and endothelium-dependent vasodilatation of resistance vessels.
Natali A; Toschi E; Baldeweg S; Casolaro A; Baldi S; Sironi AM; Yudkin JS; Ferrannini E
Eur Heart J; 2005 Mar; 26(5):464-71. PubMed ID: 15691863
[TBL] [Abstract][Full Text] [Related]
18. Urinary albumin excretion and glomerular filtration rate across the spectrum of glucose abnormalities in essential hypertension.
Redon J; Morales-Olivas F; Galgo A; Brito MA; Mediavilla J; Marín R; Rodríguez P; Tranche S; Lozano JV; Filozof C;
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S236-45. PubMed ID: 17130268
[TBL] [Abstract][Full Text] [Related]
19. Renal dysfunction impairs circadian variation of endothelial function in patients with essential hypertension.
Yamamoto K; Takeda Y; Yamashita S; Sugiura T; Wakamatsu Y; Fukuda M; Ohte N; Dohi Y; Kimura G
J Am Soc Hypertens; 2010; 4(6):265-71. PubMed ID: 20980214
[TBL] [Abstract][Full Text] [Related]
20. Changes in insulin sensitivity, renal function, and markers of endothelial dysfunction in hypertension--the impact of microalbuminuria: a 13-year follow-up study.
Solbu MD; Jenssen TG; Eriksen BO; Toft I
Metabolism; 2009 Mar; 58(3):408-15. PubMed ID: 19217459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]